Chapter 19. Primary Liver Cancer

  1. Janusz Jankowski MD, PhD, FRCP, FACG Consultant Gastroenterologist Fellow Professor11,12,13,14,15,
  2. Richard Sampliner MD Professor of Medicine Chief of Gastroenterology16,17,
  3. David Kerr CBE, MA, MD, DSc, FRCP, FMedSci Head of Department of Clinical Pharmacology15,18,19 and
  4. Yuman Fong MD Professor of Surgery20,21
  1. Charlie Pan MD1,
  2. Theodore Lawrence MD, PhD2,
  3. Jorge A. Marrerro MD, MS3,
  4. Rebecca F. Harrison BSc, MBChB, FRCPath4,
  5. Angus H. McGregor MBChB, Bsc, MD5,
  6. Jonathon Willatt MBChB, FRCR6,
  7. Hero K. Hussain MBChB, FRCR7,
  8. Shawn J. Pelletier MD8,
  9. James A. Knol MD, FACS9 and
  10. William D. Ensminger MD10

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300147.ch19

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

How to Cite

Pan, C., Lawrence, T., Marrerro, J. A., Harrison, R. F., McGregor, A. H., Willatt, J., Hussain, H. K., Pelletier, S. J., Knol, J. A. and Ensminger, W. D. (2008) Primary Liver Cancer, in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (eds J. Jankowski, R. Sampliner, D. Kerr and Y. Fong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300147.ch19

Editor Information

  1. 11

    Digestive Diseases Centre UHL Trust, Leicester, UK

  2. 12

    James Black Senior Fellow and Professor, University of Oxford, UK

  3. 13

    Cancer Research, UK

  4. 14

    Queen Mary University of London, UK

  5. 15

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  6. 16

    University of Arizona College of Medicine, Tuscon, AZ, USA

  7. 17

    Southern Arizona VA Health Care System, USA

  8. 18

    Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology, University of Oxford, UK

  9. 19

    University of Oxford, UK

  10. 20

    Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

  11. 21

    Weill Cornell Medical Center, New York, USA

Author Information

  1. 1

    Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI, USA

  2. 2

    Department of Radiation Oncology, University of Michigan, USA

  3. 3

    Multidisciplinary Liver Tumor Program, University of Michigan, Taubman Center, Ann Arbor, MI, USA

  4. 4

    Department of Pathology, Leicester General Hospital, Leicester, UK

  5. 5

    Department of Histopathology, Leicester Royal Infirmary, Leicester, UK

  6. 6

    Radiology Department, University of Michigan, Ann Arbor, MI, USA

  7. 7

    Department of Radiology / MRI, University of Michigan Health System, Ann Arbor, MI, USA

  8. 8

    General and Transplantation Surgery, Taubman Center, University of Michigan Health System, Ann Arbor, Michigan, USA

  9. 9

    Division of Gastrointestinal Surgery, University of Michigan Department of Surgery, Ann Arbor, MI, USA

  10. 10

    Upjohn Center SPC 5504, Ann Arbor, MI, USA

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405127837

Online ISBN: 9781444300147

SEARCH

Keywords:

  • primary liver cancer;
  • hepatocellular carcinoma histopathology;
  • cirrhotic liver hepatocellular carcinoma;
  • systemic chemotherapy;
  • hepatocellular carcinoma (HCC) treatment;
  • surgical resection - HCC treatment of choice;
  • ablation methods and hepatocellular cancer (HCC) management;
  • three-dimensional radiation therapy treatment planning (3D-CRT) and external-beam radiotherapy;
  • stereotactic body radiation therapy (SBRT)

Summary

This chapter contains sections titled:

  • Diagnosis

  • Imaging and staging

  • Treatment

  • Prognosis and follow-up

  • References